(Q34668921)

3 August 2017

1 reference

title

Tacrolimus: a review of its use for the management of dermatoses (English)

1 reference

3 August 2017

Gupta AK

1

1 reference

3 August 2017

Adamiak A

series ordinal

2

1 reference

3 August 2017

Chow M

series ordinal

3

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

Journal of the European Academy of Dermatology and Venereology

3 August 2017

published in

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

100-114

1 reference

FK506 in the treatment of inflammatory skin disease: promises and perspectives.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Treatment of atopic dermatitis: role of tacrolimus ointment as a topical noncorticosteroidal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Cellular and immunologic mechanisms in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Epidemiology of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Pathogenesis of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Horizons in pharmacologic intervention in allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus clearance is age-dependent within the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Therapeutic drug monitoring of immunosuppressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Human hand allograft: report on first 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Topical FK506--clinical potential or laboratory curiosity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Inhibition of contact allergy reactions by topical FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus ointment improves psoriasis in a microplaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus: pharmacology and therapeutic uses in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Erosive mucosal lichen planus: response to topical treatment with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Anti-tumor-promoting action of FK506, a potent immunosuppressive agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Topical tacrolimus in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

Rational design of new immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2002.00380.X

10.1046/J.1468-3083.2002.00380.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference